Total Payments
$7,130
2024 Payments
$151.60
Companies
39
Transactions
505
Medicare Patients
4,221
Medicare Billing
$275,355
Payment Breakdown by Category
Food & Beverage$7,084 (99.3%)
Education$46.58 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,084 | 498 | 99.3% |
| Education | $46.58 | 7 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $924.17 | 47 | $0 (2023) |
| Novo Nordisk Inc | $901.97 | 82 | $0 (2024) |
| AbbVie Inc. | $766.39 | 43 | $0 (2023) |
| PFIZER INC. | $642.09 | 52 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $415.12 | 44 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $380.92 | 22 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $378.99 | 28 | $0 (2022) |
| Amgen Inc. | $376.74 | 27 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $324.09 | 13 | $0 (2021) |
| Takeda Pharmaceuticals U.S.A., Inc. | $253.18 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $151.60 | 15 | Novo Nordisk Inc ($131.31) |
| 2023 | $745.81 | 48 | AbbVie Inc. ($143.00) |
| 2022 | $497.60 | 30 | Novo Nordisk Inc ($199.28) |
| 2021 | $415.15 | 23 | Novo Nordisk Inc ($152.53) |
| 2020 | $285.38 | 19 | PFIZER INC. ($48.33) |
| 2019 | $1,891 | 154 | PFIZER INC. ($231.98) |
| 2018 | $1,449 | 106 | PFIZER INC. ($194.34) |
| 2017 | $1,695 | 110 | AstraZeneca Pharmaceuticals LP ($489.09) |
All Payment Transactions
505 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.24 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: Obesity | ||||||
| 11/08/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $9.88 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Obesity | ||||||
| 10/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Obesity | ||||||
| 10/03/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.70 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.60 | General |
| Category: Diabetes | ||||||
| 08/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Diabetes | ||||||
| 06/11/2024 | Novo Nordisk Inc | Wegovy (Drug) | Education | In-kind items and services | $8.90 | General |
| Category: Obesity | ||||||
| 05/14/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.62 | General |
| Category: Obesity | ||||||
| 04/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.57 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.64 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $8.76 | General |
| Category: Obesity | ||||||
| 02/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: PAIN | ||||||
| 01/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: Diabetes | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), TRULANCE | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Gastroenterology | ||||||
| 11/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Obesity | ||||||
| 11/03/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.78 | General |
| Category: Diabetes | ||||||
| 11/02/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.03 | General |
| Category: NEUROSCIENCE | ||||||
| 10/31/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Respiratory | ||||||
| 10/24/2023 | AbbVie Inc. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/23/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: PAIN | ||||||
| 10/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $7.19 | General |
| Category: Diabetes | ||||||
| 10/16/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Diabetes | ||||||
| 10/04/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.44 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,226 | 1,802 | $238,545 | $81,901 |
| 2022 | 22 | 1,208 | 1,832 | $237,588 | $79,850 |
| 2021 | 23 | 1,181 | 1,740 | $202,998 | $70,791 |
| 2020 | 10 | 606 | 777 | $147,960 | $42,813 |
Total Patients
4,221
Total Services
6,151
Medicare Billing
$275,355
Procedure Codes
77
All Medicare Procedures & Services
77 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 209 | 472 | $137,824 | $42,062 | 30.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 138 | 138 | $41,124 | $17,113 | 41.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 54 | 64 | $13,184 | $4,126 | 31.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 37 | 39 | $4,758 | $2,788 | 58.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $8,648 | $2,715 | 31.4% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 12 | 12 | $4,524 | $1,919 | 42.4% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 95 | 141 | $5,640 | $1,829 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 114 | 193 | $3,116 | $1,583 | 50.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 106 | 152 | $4,712 | $1,557 | 33.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 37 | 39 | $1,950 | $1,163 | 59.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 62 | 85 | $2,125 | $801.52 | 37.7% |
| 82306 | Vitamin d-3 level | Office | 2023 | 23 | 26 | $1,560 | $754.26 | 48.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 36 | 44 | $2,200 | $724.24 | 32.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 74 | 91 | $1,820 | $686.38 | 37.7% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 68 | 101 | $1,212 | $567.10 | 46.8% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 64 | 90 | $990.00 | $453.11 | 45.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 15 | 16 | $960.00 | $236.48 | 24.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $559.00 | $231.14 | 41.3% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 11 | 11 | $440.00 | $208.12 | 47.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 22 | $704.00 | $184.96 | 26.3% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 13 | 15 | $300.00 | $132.60 | 44.2% |
| 84550 | Uric acid level, blood | Office | 2023 | 11 | 15 | $195.00 | $66.45 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 208 | 475 | $138,700 | $41,127 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 121 | 121 | $36,058 | $15,400 | 42.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 52 | $10,712 | $3,367 | 31.4% |
About Peter Young
Peter Young is a Internal Medicine healthcare provider based in Avondale, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1376543108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Peter Young has received a total of $7,130 in payments from pharmaceutical and medical device companies, with $151.60 received in 2024. These payments were reported across 505 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($7,084).
As a Medicare-enrolled provider, Young has provided services to 4,221 Medicare beneficiaries, totaling 6,151 services with total Medicare billing of $275,355. Data is available for 4 years (2020–2023), covering 77 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Avondale, AZ
- Active Since 07/22/2005
- Last Updated 04/18/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1376543108
Products in Payments
- FARXIGA (Drug) $646.11
- Ozempic (Drug) $327.61
- JANUVIA (Drug) $317.94
- CHANTIX (Drug) $285.96
- JARDIANCE (Drug) $245.01
- INVOKANA (Drug) $220.87
- Trintellix (Drug) $197.23
- Tymlos (Biological) $174.89
- Prolia (Biological) $139.50
- UBRELVY (Drug) $137.71
- VRAYLAR (Drug) $129.42
- TOUJEO (Drug) $128.22
- EVENITY (Biological) $128.21
- TRULICITY (Drug) $127.63
- PREVNAR - 13 (Biological) $123.67
- GLYXAMBI (Drug) $120.23
- Synthroid (Drug) $118.12
- XIFAXAN (Drug) $114.27
- Androgel (Drug) $113.61
- YOSPRALA (Drug) $106.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Avondale
Dr. Hursh Naik, Md, MD
Internal Medicine — Payments: $691,143
Internal Medicine $691,143
Arun Patil, M.d, M.D
Internal Medicine — Payments: $25,286
Internal Medicine $25,286
Dr. Muhammad Khakwani, Md, MD
Internal Medicine — Payments: $22,150
Internal Medicine $22,150
Dr. Vikram Kapur, M.d, M.D
Internal Medicine — Payments: $10,150
Internal Medicine $10,150
Dr. Ravi Galhotra, M.d, M.D
Internal Medicine — Payments: $8,893
Internal Medicine $8,893
Dr. Terry Woodbeck, Md, MD
Internal Medicine — Payments: $5,913
Internal Medicine $5,913